Romosozumab in postmenopausal women with low bone mineral density.

McClung, Michael R

Romosozumab in postmenopausal women with low bone mineral density. [electronic resource] - The New England journal of medicine Jan 2014 - 412-20 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa1305224 doi


Aged
Aged, 80 and over
Alendronate--pharmacology
Antibodies, Monoclonal--administration & dosage
Biomarkers--metabolism
Bone Density--drug effects
Bone Density Conservation Agents--administration & dosage
Bone Remodeling--drug effects
Calcium--blood
Drug Administration Schedule
Female
Humans
Injections, Subcutaneous
Least-Squares Analysis
Lumbar Vertebrae--drug effects
Middle Aged
Osteoporosis, Postmenopausal--drug therapy
Teriparatide--pharmacology